These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36716991)

  • 1. Association of serum uric acid with benefits of intensive blood pressure control.
    Wang XQ; Tan JS; Zhang SY; Zhang WL; Cai J
    Rev Esp Cardiol (Engl Ed); 2023 Aug; 76(8):635-644. PubMed ID: 36716991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of baseline serum cholesterol with benefits of intensive blood pressure control.
    Wang X; Feng Y; Yang L; Zhang G; Tian X; Ling Q; Tan J; Cai J
    Chin Med J (Engl); 2023 Sep; 136(17):2058-2065. PubMed ID: 37525354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remnant cholesterol and intensive blood pressure control in older patients with hypertension: a post hoc analysis of the STEP randomized trial†.
    Yang R; Zhang J; Yu X; Yang G; Cai J
    Eur J Prev Cardiol; 2024 Jun; 31(8):997-1004. PubMed ID: 38167928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial).
    Shapiro BP; Ambrosius WT; Blackshear JL; Cushman WC; Whelton PK; Oparil S; Beddhu S; Dwyer JP; Gren LH; Kostis WJ; Lioudis M; Pisoni R; Rosendorff C; Haley WE;
    Hypertension; 2018 Jun; 71(6):1064-1074. PubMed ID: 29712745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
    Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive blood pressure lowering and the risk of new-onset diabetes in patients with hypertension: a post-hoc analysis of the STEP randomized trial.
    Yang R; Zhu Y; Xu M; Tao Y; Cong W; Cai J
    Eur J Prev Cardiol; 2023 Aug; 30(10):988-995. PubMed ID: 37036035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
    Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
    JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
    Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieved systolic blood pressure and cardiovascular outcomes in 60-80-year-old patients: the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial.
    Deng Y; Bai J; Yang X; Liu W; Guo Z; Zhang J; Huang R; Yang X; Yu C; Yu J; Guo X; Wu H; Liu P; Zhang W; Cai J
    Eur J Prev Cardiol; 2023 Aug; 30(10):1017-1027. PubMed ID: 37172116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of baseline arterial stiffness on effects of intensive compared with standard blood pressure control: a post hoc analysis of the STEP trial.
    Song Q; Ling Q; Bai J; Zhang H; Bu P; Chen F; Wu S; Zhang W; Chen M; Cai J
    BMC Med; 2022 Oct; 20(1):358. PubMed ID: 36261812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of intensive blood pressure management with cardiovascular outcomes in patients using multiple classes of antihypertensive medications: a post-hoc analysis of the STEP Trial.
    Zhang K; Song Q; Bai J; Cai J
    Hypertens Res; 2024 Jul; 47(7):1779-1788. PubMed ID: 38600278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of baseline glycemic status on the effects of intensive blood pressure lowering: Results from the STEP randomized trial.
    Yang R; Wang Y; Tong A; Yu J; Zhao D; Cai J
    Eur J Intern Med; 2023 Jul; 113():75-82. PubMed ID: 37142449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Zhang L; Sun X; Liao L; Zhang S; Zhou H; Zhong X; Zhuang X; Liao X
    J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1813-1820. PubMed ID: 31670874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intensive blood pressure lowering in patients with diabetes: A pooled analysis of the STEP and ACCORD-BP randomized trials.
    Yang R; Bai J; Fang Z; Wang Y; Feng Y; Liu Y; Chi H; Deng Y; Song Q; Cai J
    Diabetes Obes Metab; 2023 Mar; 25(3):796-804. PubMed ID: 36433919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering: Results From the STEP Randomized Trial.
    Yang R; Huang R; Zhang L; Li D; Luo J; Cai J
    Hypertension; 2023 Dec; 80(12):2572-2580. PubMed ID: 37814892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
    Dolui S; Detre JA; Gaussoin SA; Herrick JS; Wang DJJ; Tamura MK; Cho ME; Haley WE; Launer LJ; Punzi HA; Rastogi A; Still CH; Weiner DE; Wright JT; Williamson JD; Wright CB; Bryan RN; Bress AP; Pajewski NM; Nasrallah IM
    JAMA Neurol; 2022 Apr; 79(4):380-389. PubMed ID: 35254390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systolic blood pressure trajectory and cardiovascular outcomes: An analysis using data in the Systolic Blood Pressure Intervention Trial.
    Lee CL; Wang JS
    Int J Clin Pract; 2020 Mar; 74(3):e13450. PubMed ID: 31755625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
    JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Pajewski NM; Berlowitz DR; Bress AP; Callahan KE; Cheung AK; Fine LJ; Gaussoin SA; Johnson KC; King J; Kitzman DW; Kostis JB; Lerner AJ; Lewis CE; Oparil S; Rahman M; Reboussin DM; Rocco MV; Snyder JK; Still C; Supiano MA; Wadley VG; Whelton PK; Wright JT; Williamson JD
    J Am Geriatr Soc; 2020 Mar; 68(3):496-504. PubMed ID: 31840813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.